Vardenafil and weaning from inhaled nitric oxide: Effect on pulmonary hypertension in ARDS

Anaesthesia and Intensive Care

Volumn 35, Issue 1, 2007, Pages 91-93

  Giacomini, M ^a,b   Borotto, E ^a   Bosotti, L ^a   Denkewitz, T ^a   Reali Forster, C ^a   Carlucci, P ^a   Centanni, S ^a   Mantero, A ^a   Iapichino, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Istituto di Anestesiologia e Rianimazione   (Italy)

Author keywords

Acute respiratory distress syndrome; Nitric oxide; PDE 5 inhibitor; Pulmonary hypertension

Indexed keywords

DOBUTAMINE; INFUSION FLUID; NITRIC OXIDE; NORADRENALIN; VARDENAFIL;

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HUMAN; HYPOTENSION; LONG TERM CARE; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; PULMONARY HYPERTENSION; RETREATMENT; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMIDAZOLES; MIDDLE AGED; NITRIC OXIDE; PIPERAZINES; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SALVAGE THERAPY; SULFONES; TRIAZINES; VASODILATOR AGENTS;

EID: 33847376504     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0703500113     Document Type: Article

References (10)

1. Ware L, Matthay M. Medical Progress: The acute respiratory distress syndrome. N Engl J Med 2000; 348:1334-1349.
2. Moloney ED, Evans TW. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur Respir J 2003; 21:720-727.
3. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405.
4. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med 2003; 29:1996-2003.
5. Bigatello LM, Hess D, Dennehy KC, Medoff BD, Hurford WE. Sildenafil can increase the response to inhaled nitric oxide. Anesthesiology 2000; 92:1827-1829.
6. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 2002; 360:895-899.
7. Vardenafil (levitra) for erectile dysfunction. Med Lett Drugs Ther 2003; 45:77-78.
8. Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadas B et al. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol 2004; 44:1488.
9. Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure: from pathophysiology to new treatments. Intensive Care Med 2004; 30:185-196.
10. Christenson J, Lavoie A, O'Connor M, Bhorade S, Pohlman A, Hall JB. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 2000; 161:1443-1449.